Hepatic Steatosis with Hepatitis B Virus/Hepatitis C Virus Dual Infection

Hepatology

Volumn 52, Issue 4, 2010, Pages 1521-1522

  Hung, Chao Hung ^a   Lee, Chuan Mo ^a   Lu, Sheng Nan ^a   Wang, Jing Houng ^a   Chen, Chien Hung ^a   Hu, Tsung Hui ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASIAN; CASE CONTROL STUDY; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; NOTE; PATHOLOGY; PREVALENCE; STATISTICS; TAIWAN; VIROLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TAIWAN;

EID: 77957964144     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23740     Document Type: Letter

References (9)

1. Bini EJ, Perumalswami PV. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions. HEPATOLOGY 2010;51:759-766.
2. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. HEPATOLOGY 1995;22:1101-1108.
3. Hung CH, Lee CM, Lu SN, Wang JH, Tung HD, Chen CH, et al. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J Gastroenterol Hepatol 2005;20:727-732.
4. Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009;136:496-504.
5. French METAVIR Cooperative Study Group. Intraobserver and inter-observer variations in liver biopsy interpretation in patients with chronic hepatitis C. HEPATOLOGY 1994;20:15-20.
6. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. HEPATOLOGY 2001;33:1358-1364.
7. Hung CH, Kuo FY, Wang JH, Lu SN, Hu TH, Chen CH, et al. Impact of steatosis on long-term histological outcome in chronic hepatitis C after antiviral therapy. Antivir Ther 2006;11:483-489.
8. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol 2005;43:38-44.
9. Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. HEPATOLOGY 2009;49:1859-1867.